SDEV — Stablecoin Development Share News
0.000.00%
Last trade - 00:00Brief: NovaBay Says Hypochlorous Acid Solution Got U.S. EPA Approval For SARS-CoV-2 Kill Claim
Brief: Novabay Pharmaceuticals Expands Avenova's Geographic Reach To Australia With New Exclusive Distribution Agreement
Brief: NovaBay Reports Q3 Loss Per Share Of $0.08
Brief: Novabay Announces Consumer Launch Of Cellerx Clinical Reset
AMEX HALT EQUIPMENT CHANGEOVER LAST 0.613300
Brief: Novabay Pharma Regains Compliance With NYSE American Listing Standards
NovaBay Pharma rises on marketing boost for facial sanitizer
Brief: Novabay Pharmaceuticals Entered First Amendment To That Certain Services Agreement With TLF Bio Innovation Lab
Brief: NovaBay Appoints CEO Justin Hall To Its Board Of Directors
Brief: Novabay Pharmaceuticals Files Prospectus For Resale Of 6.9 Mln Warrant Shares
NovaBay Pharma: Rises after co rolls out sanitizer on Walmart.com
Brief: NovaBay Pharmaceuticals Expands Avenova's Online Distribution
Brief: Novabay Pharmaceuticals Reports Second Quarter 2020 Financial Results
Brief: Novabay Says Anticipates Reporting Q2 Net Sales Increased By About 100% And Operating Loss Declined By About 25% From Prior Quarter
NovaBay Pharma up on data showing antimicrobial spray effective against coronavirus
Brief: Novabay Says Laboratory Results Confirm Avenova Kills Sars-Cov-2 (Covid-19 Virus)
Brief: NovaBay Pharmaceuticals Files For Offering Of Up To $5.6 Mln Of Shares Of Common Stock
Brief: NovaBay Says It Files Prospectus Related To Resale Of 10.2 Million Shares Held By Stockholders
Brief: NovaBay Pharmaceuticals Says Entered Second Amendment To Certain Promissory Note